Suhir Paul
Paul’s work as a Professor at the Universities of Nebraska and Texas has brought catabodies/E-vaccines from chemical curiosities to the verge of medical use. His research was funded continuously by the NIH, non-profit foundations and biotech companies since 1983. His early discovery patents were bought out (USD 21 MM) by Abgenix in 2001. He discovered harmful catabodies in autoimmune disease, prog...
N/A
Technology
N/A
Founded
N/A
Employees
N/A
Industry
Visual (Placeholder)
Profile Information
Name
Suhir Paul
Industry
N/A
Technology
N/A
Location
USA
Founded
N/A
Employees
N/A
Category
Entrepreneur
Contact Information
Email
N/A
Phone
N/A
Address
N/A